Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression

被引:10
|
作者
Tomizawa, Minoru [1 ]
Shinozaki, Fuminobu [2 ]
Motoyoshi, Yasufumi [3 ]
Sugiyama, Takao [4 ]
Yamamoto, Shigenori [5 ]
Ishige, Naoki [6 ]
机构
[1] Natl Hosp Org, Shimoshizu Hosp, Dept Gastroenterol, Chiba 2840003, Japan
[2] Natl Hosp Org, Shimoshizu Hosp, Dept Radiol, Chiba 2840003, Japan
[3] Natl Hosp Org, Shimoshizu Hosp, Dept Neurol, Chiba 2840003, Japan
[4] Natl Hosp Org, Shimoshizu Hosp, Dept Rheumatol, Chiba 2840003, Japan
[5] Natl Hosp Org, Shimoshizu Hosp, Dept Pediat, Chiba 2840003, Japan
[6] Natl Hosp Org, Shimoshizu Hosp, Dept Neurosurg, Chiba 2840003, Japan
关键词
scratch assay; quantitative polymerase chain reaction; MTS assay; CYCLIN D1; CANCER; INVASION;
D O I
10.3892/ol.2015.3789
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastasis negatively affects the prognosis of hepatocellular carcinoma (HCC). In the present study, niclosamide, which is known to suppress the proliferation of HCC cells, was investigated for possible suppressant effects on the migration of HCC cells. HLF and PLC/PRF/5 HCC cells were cultured in the presence of niclosamide. Cell proliferation was analyzed using the MTS assay. Cell migration was measured by performing a scratch assay. Expression levels of cyclin D1 and matrix metalloproteinase 9 (MMP9) were analyzed by performing revers transcription-quantitative polymerase chain reaction. Compared with the control treatment, treatment with 10 mu m niclosamide suppressed the proliferation of the HLF and PRL/PRF/5 cells to 49.9 +/- 3.7 and 17.9 +/- 11.5% (P<0.05), respectively. Furthermore, compared with the control treatment, treatment with 1.0 mu M niclosamide downregulated the expression of cyclin D1 to 52.4 +/- 4.4 and 23.9 +/- 5.4% (P<0.05) in the HLF and PRL/PRF/5 cells, respectively. In the scratch assay, treatment of the HLF cells with niclosamide (1.0 mu m) decreased the distance of the scratched line from the growing edge to 4.6 +/- 1.0 mm compared with the 9.2 +/- 1.4 mm observed with the control treatment (P<0.05). Similarly, treatment of the PRL/PRF/5 cells with niclosamide (1.0 mu m) also decreased the distance of the scratched line from the growing edge to 3.0 +/- 0.8 mm compared with the 5.5 +/- 0.9 mm observed with the control treatment (P<0.05). Further, MMP9 expression levels in the HLF cells treated with 1.0 mu m niclosamide decreased to 22.4 +/- 1.76% (P<0.05) compared with those in the untreated control HLF cells. Similarly, expression level of MMP9 in the PRL/PRF/5 cells treated with 1.0 mu m niclosamide deceased to 18.7 +/- 10.7% (P<0.05) compared with those in the untreated control PRL/PRF/5 cells. Overall, niclosamide downregulated the expression of MMP9 in and suppressed the migration of HCC cells.
引用
收藏
页码:3515 / 3518
页数:4
相关论文
共 50 条
  • [1] Wogonin Suppresses the Activity of Matrix Metalloproteinase-9 and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma
    Hong, Ming
    Cheng, Honghui
    Song, Lei
    Wang, Wencai
    Wang, Qi
    Xu, Donggang
    Xing, Weiwei
    MOLECULES, 2018, 23 (02):
  • [2] Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells
    Yu, Hai-Bo
    Zhang, Hui-Feng
    Li, De-Yu
    Zhang, Xiao
    Xue, Huan-Zhou
    Zhao, Si-Hai
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2011, 13 (03) : 242 - 250
  • [3] Matrine suppresses lung metastasis of human hepatocellular carcinoma by directly targeting matrix metalloproteinase-9
    Zhang, Juyuan
    Gao, Yuan
    Han, Hui
    Zou, Changlin
    Feng, Yu
    Zhang, Hui
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (01) : 57 - 63
  • [4] Expression of Matrix Metalloproteinase-9 In Predicting Prognosis of Hepatocellular Carcinoma After Liver Transplantation
    Nart, Deniz
    Yaman, Banu
    Yilmaz, Funda
    Zeytunlu, Murat
    Karasu, Zeki
    Kilic, Murat
    LIVER TRANSPLANTATION, 2010, 16 (05) : 621 - 630
  • [5] Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells
    Yeh, Ming-Hsien
    Kao, Shung-Te
    Hung, Che-Ming
    Liu, Ching-Ju
    Lee, Kuo-Hua
    Yeh, Chia-Chou
    TOXICOLOGY LETTERS, 2009, 184 (03) : 204 - 210
  • [6] Serum Amyloid A Downregulates Elastin and Upregulates Matrix Metalloproteinase-9 Gene Expression in Smooth Muscle Cells
    Seidl, Stephanie
    Rich, Celeste B.
    Sullivan, Christopher P.
    Stone, Phillip J.
    Schreiber, Barbara M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E47 - E47
  • [7] Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma
    Murawaki, Y
    Ikuta, Y
    Okamoto, K
    Mimura, K
    Koda, M
    Kawasaki, H
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 2000, 108 (5-6) : 351 - 357
  • [8] Expression levels of matrix metalloproteinase-9 in human gastric carcinoma
    Chen, Su-Zuan
    Yao, Huai-Qi
    Zhu, Sen-Zhi
    Li, Qiu-Yuan
    Guo, Guang-Hua
    Yu, Jing
    ONCOLOGY LETTERS, 2015, 9 (02) : 915 - 919
  • [9] Cordycepin Suppresses TNF-alpha-induced Invasion, Migration and Matrix Metalloproteinase-9 Expression in Human Bladder Cancer Cells
    Lee, Eo-Jin
    Kim, Wun-Jae
    Moon, Sung-Kwon
    PHYTOTHERAPY RESEARCH, 2010, 24 (12) : 1755 - 1761
  • [10] Isocitrate Dehydrogenase 2 Suppresses the Invasion of Hepatocellular Carcinoma Cells via Matrix Metalloproteinase 9
    Tian, Guo-Yan
    Zang, Shu-Fei
    Wang, Lei
    Luo, Yan
    Shi, Jun-Ping
    Lou, Guo-Qiang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 37 (06) : 2405 - 2414